Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Preliminary results of SYMPHONY indicate that Xubix is effective in acute coronary syndromes

Aug. 9, 1999

Teijin prepares factor Xa inhibitor series

Aug. 6, 1999

Health Canada approves Integrilin for marketing

Aug. 6, 1999

Hoechst Marion Roussel reveals new anticoagulants with advantages over heparin

Aug. 4, 1999

Genentech seeks FDA approval for tenecteplase

Aug. 3, 1999

New thrombin inhibitor approved in Italy for antithrombotic prophylaxis

July 29, 1999

Anthranilide anticoagulants developed by Schering AG researchers

July 29, 1999

Antiplatelet agents acting as IP receptor agonists developed at Fujisawa

July 23, 1999

Brain '99: lanoteplase improves microcirculation in ischemic brain

July 22, 1999

Wide series of factor Xa inhibitors specifically claimed by DuPont

July 20, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...